Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma (NCT04301843)

🧪 Interventions in This Study

• Eflornithine (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (31 Sites)

Showing the first 25 of 31 sites.

• University of Alabama/Children's of Alabama — Birmingham, Alabama
• Arkansas Children's Hospital — Little Rock, Arkansas
• UCSF Benioff Children's Hospital Oakland — Oakland, California
• Rady Children's Hospital — San Diego, California
• Connecticut Children's Hospital — Hartford, Connecticut
• Arnold Palmer Hospital for Children — Orlando, Florida
• St. Joseph's Children's Hospital — Tampa, Florida
• Augusta University Health — Augusta, Georgia
• University of Iowa — Iowa City, Iowa
• Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine — Louisville, Kentucky
• Helen DeVos Children's Hospital — Grand Rapids, Michigan
• Children's Hospital and Clinics of Minnesota — Minneapolis, Minnesota
• Children's Mercy Hospitals and Clinics — Kansas City, Missouri
• Cardinal Glennon Children's Hospital — St Louis, Missouri
• Hackensack University Medical Center — Hackensack, New Jersey
• Levine Children's Hospital — Charlotte, North Carolina
• Cleveland Clinic Children's — Cleveland, Ohio
• Randall Children's Hospital — Portland, Oregon
• Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania
• Hasbro Children's Hospital — Providence, Rhode Island
• Medical University of South Carolina — Charleston, South Carolina
• Dell Children's Blood and Cancer Center — Austin, Texas
• Children's Medical Center Dallas — Dallas, Texas
• Children's Hospital of The King's Daughters — Norfolk, Virginia
• Medical College of Wisconsin — Milwaukee, Wisconsin

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Neuroblastoma

• Open-Label Study of 18F-mFBG for Imaging Neuroblastoma — Los Angeles, California
• Neuroblastoma Precision Trial — Los Angeles, California
• Neuroblastoma Maintenance Therapy Trial — Birmingham, Alabama
• Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow — Indianapolis, Indiana
• A Study of N9 Chemotherapy in Children With Neuroblastoma — New York, New York
• A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma — San Francisco, California

Explore by condition: All Neuroblastoma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.